Norelgestromin: profile and news

Transdermal Patches: An Innovative Drug Delivery System That Has ... 07 Mar 2006
...report published by the Associated Press on July 18, 2005 linked the birth control patch, which contains a combination of norelgestromin and ethinyl estradiol ... - Newsinferno.com,

Results of Two Epidemiological Studies Provide Important New ... Feb 16, 2006
16 /PRNewswire/ -- Ortho Women's Health & Urology, the maker of the ORTHO EVRA(R) (norelgestromin/ethinyl estradiol transdermal system) birth control patch ... - International News Service,

Parker & Waichman, LLP Files Suit Against Ortho-McNeil ... Feb 24, 2006
...torso. The patch is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream per 24 hours. ... - Emediawire (press release),

Evidence on Ortho Evra Patch Thrombosis Risk Is Contradictory Feb 17, 2006
Interim results of an epidemiologic study indicated that women who use Ortho Evra (norelgestromin/ethinyl estradiol transdermal system) had about a two-fold ... - MedPage Today,

FDA: Birth Control Patch Needs More Study Feb 17, 2006
...company. Like the Pill, ORTHO EVRA contains two hormones – an estrogen, ethinyl estradiol, and a progestin, norelgestromin. When ... - Consumer Affairs

Blood clot warning to go on Ortho Evra birth control patch Feb 19, 2006
Ortho Evra is a weekly prescription patch that releases ethinyl estradiol (an estrogen hormone) and norelgestromin (a progestin hormone) through the skin into ... - News-Medical.net,

Results of Two Epidemiological Studies Provide Important New ... Feb 17, 2006
RARITAN, NJ, February 16, 2006 /PRNewswire/ -- Ortho Women's Health & Urology, the maker of the ORTHO EVRA(R) (norelgestromin/ethinyl estradiol transdermal ... - PharmaLive.com (press release),

Studies Of Birth-control Patch REvelaed Important New Clinical ... Feb 18, 2006
Ortho Women's Health & Urology, the maker of the ORTHO EVRA (norelgestromin/ethinyl estradiol transdermal system) birth control patch, has received the first ... - Playfuls.com,

PRN/BW Texas Jan 27, 2006
...torso. The patch is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream per 24 hours. ... - Houston Chronicle,

Ortho Evra (norelgestromin/ethinyl estradiol) Information Nov 12, 2005
By US Food and Drug Administration. FDA is announcing a revision to the label for the drug Ortho Evra, the only skin patch approved for birth control. ... - Community Dispatch (press release)

Women Using the Ortho Evra Birth Control Patch Warned of Increased ... Nov 11, 2005
...report published by the Associated Press on July 18, 2005 linked the birth control patch, which contains a combination of norelgestromin and ethinyl estradiol ... - Newsinferno.com,

Parker & Waichman, LLP Files Suit Against Ortho-McNeil ... Dec 7, 2005
...torso. The patch is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream per 24 hours. ... - PrimeZone (press release),

Ortho Evra contraceptive patch exposes women to higher levels of ... Nov 15, 2005
It is a weekly prescription patch that releases EthinylEestradiol ( an estrogen hormone ) and Norelgestromin ( a progestin hormone ) through the skin into the ... - Xagena.it,

US FDA warns about J&J patch hormone levels Nov 10, 2005
Ortho Evra, the first contraceptive patch on the US market, releases the estrogen hormone ethinyl estradiol and a progestin hormone norelgestromin into the ... - Reuters.uk,

FDA says patch has blood clot risk Nov 11, 2005
The patch releases ethinyl estradiol, an estrogen hormone, and norelgestromin, a progestin hormone, through the skin into the blood stream. ... - CNN

New Prescribing Information Announced for ORTHO EVRA(R) Birth ... Nov 10, 2005
...unit of Ortho-McNeil Pharmaceutical, Inc., has updated the WARNINGS section of the prescribing information for ORTHO EVRA(R) (norelgestromin/ethinyl estradiol ... - PR Newswire (press release),

FDA Updates Labeling for Ortho Evra Contraceptive Patch Nov 11, 2005
It is a weekly prescription patch that releases ethinyl estradiol (an estrogen hormone) and norelgestromin (a progestin hormone) through the skin into the ... - DG News

FDA warns of hormone patch's clotting risk Nov 11, 2005
The patch releases ethinyl estradiol, an estrogen hormone, and norelgestromin, a progestin hormone, through the skin into the blood stream. - United Press International

FDA warns on contraceptive patch Nov 11, 2005
Ortho Evra contraceptive patch, which only needs to be changed once a week, releases ethinyl estradiol, an estrogen hormone, and norelgestromin, a progestin ... - United Press International

Parker & Waichman, LLP Believes Warning Issued by Johnson & ... Nov 11, 2005
Ortho Evra is an adhesive, transdermal birth control patch that is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the ... - PrimeZone (press release),

FAQ: Ortho Evra Contraceptive Patch Nov 11, 2005
It is a weekly prescription patch that releases ethinyl estradiol (an estrogen hormone) and norelgestromin (a progestin hormone) through the skin into the ... - Food Consumer,

Parker & Waichman, LLP Comments on Published Study Underscoring ... Sep 26, 2005
Ortho Evra is an adhesive, transdermal birth control patch that is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the ... - PrimeZone (press release),

Parker & Waichman, LLP, Files Suit Against Ortho-McNeil ... Sep 13, 2005
...torso. The patch is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream per 24 hours. ... - PharmaLive.com (press release),

'Charmed' Television Star Partners With Ortho Women's Health to Go ... Sep 20, 2005
...and marketer of ORTHO EVRA(R) (norelgestromin/ethinyl estradiol transdermal system), ORTHO TRI-CYCLEN(R) LO (ethinyl estradiol/norgestimate) and ORTHO TRI ... - PR Newswire (press release),

Parker & Waichman, LLP Files Application Requesting Designation of ... Sep 1, 2005
The patch is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream every 24 hours. ... - PrimeZone (press release),

First line of defence Aug 30, 2005
...countries for several years. A combined method, it releases 20µg ethinyloestradiol and 150µg norelgestromin daily. A new patch ... - AustralianDoctor.com (subscription),

Parker & Waichman, LLP Files Suit Against Ortho-McNeil ... Jul 29, 2005
...torso. The patch is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream per 24 hours. ... - PrimeZone (press release)

Birth Control Patch May Be Linked to Stroke Risk Jul 19, 2005
...risk factors. The patch releases 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream per 24 hours. It ... - MedPage Today <**results**>

Contraception During Perimenopause Jun 22, 2005
It delivers ethinylestradiol and norelgestromin (17- deacetylnorgestimate), over a 3-week period, like the OCs and the contraceptive vaginal ring. ... - RedNova.com

Contraceptive patches cut headaches Jun 7, 2005
In a study sponsored by Ortho Women's Health, a subsidiary of Johnson & Johnson, doctors said continuous use of ORTHO EVRA (norelgestromin/ethinyl estradiol ... - Washington Times,

CWH: Continuous Use of Contraceptive Patch a Remedy for Withdrawal ... Jun 8, 2005
...headache study is a sub-study of a larger trial testing whether extended use or cyclical use of the contraceptive Ortho Evra (norelgestromin/ethnyl estradiol ... - MedPage Today,

New Survey Suggests Overlooked Side Effect Causes Many Women to ... Apr 25, 2005
About Ortho Women's Health For more than 73 years, Ortho Women's Health, makers of ORTHO TRI-CYCLEN LO and ORTHO EVRA(R) (norelgestromin/ethinyl estradiol ... - PR Newswire

New Survey Suggests Overlooked Side Effect Causes Many Women to ... Apr 25, 2005
For more than 73 years, Ortho Women’s Health, makers of ORTHO TRI-CYCLEN LO and ORTHO EVRA(R) (norelgestromin/ethinyl estradiol transdermal system), a ... - mysan.de (Pressemitteilung)

Contraceptive gel from Antares Pharma advances Apr 6, 2005
...a contraceptive transdermal gel. The product, AP-1081, is gel-based and contains norelgestromin and ethinyl estradiol. It is a clear ... - Philadelphia Business Journal

Antares Pharma Unveils Proprietary Contraceptive Transdermal Gel Apr 6, 2005
...gel technology. The product, currently named AP-1081, is gel-based and contains norelgestromin and ethinyl estradiol (EE). AP-1081 ... - Yahoo News